TRILEA
TRILEA, licence 80067612: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Kotolena Pharmaceuticals and Cosmetics Inc.
- NPN or DIN-HM
- 80067612
- Status
- Active licence
- Licence date
- 11 March 2016
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bêta-alanine Source : Ester d'éthyle de bêta-alanine | 400.0 milligramme | Not calculated |
| Extrait d'isoflavones de trèfle rouge Source : Trifolium pratense - sommité (herbe) Dry plant equivalent : 100 mg Potency : 40.0 mg ÉAI Total Isoflavone (calculated as sum of sissotrin, daidzein, ononin, genistein, formononetin, abiochanin F) | 100.0 milligramme | Not calculated |
| Origanum vulgare Source : Feuille Extraction ratio : 10:1 Dry plant equivalent : 500 milligramme | 50.0 milligramme | Not calculated |
Non-medicinal ingredients
Carmine, Microcrystalline cellulose, Hydroxypropyl methylcellulose, Stéarate de magnésium, Dioxyde de titane, Glycérine, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Femmes ménopausées et en postménopause | Not specified | minimum: 1.0 Comprimé ; maximum: 2.0 Comprimé | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Women's herbal formula that supports post-menopausal health and helps relieve menopausal symptoms. May reduce severe and frequent hot flashes/flushes and night sweats in post-menopausal women. Helps to attenuate/reduce bone mineral density losses with adequate intake of calcium and vitamin D in post-menopausal women. Source of Beta-alanine amino acid.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80067612
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.